Help - Search - Members - Calendar
Full Version: Heart-Failure
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Cardiology > Heart-Failure
Pages: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
  1. Heart-Failure: Practical utility of rapid analytical determinations for the diagnosis of acute coronary syndrome, pulmonary thromboembolism and heart failure in extrahospital emergency services. (0 replies)
  2. Heart-Failure: Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure (0 replies)
  3. Heart-Failure: Reverse at 18 months: questions about crt for mild heart failure remain (0 replies)
  4. Heart-Failure: Icd do not impact on qol but shocks may signal death risk (0 replies)
  5. Heart-Failure: Rosuvastatin doesn't rate in chronic heart failure (0 replies)
  6. Heart-Failure: The under-use of -blockers for treating chronic heart failure (hf) might be explained by the deteriorations associated with advanced disease. (0 replies)
  7. Heart-Failure: Resting hr predictive of heart failure in stable cad (0 replies)
  8. Heart-Failure: The under-use of -blockers for treating chronic heart failure (hf) might be explained by the deteriorations associated with advanced disease. (0 replies)
  9. Heart-Failure: Prognostic value of changes in n-terminal pro-brain natriuretic peptide in val-heft (valsartan heart failure trial) (0 replies)
  10. Heart-Failure: Myocardial tissue doppler echocardiography and n-terminal b-type natriuretic peptide (nt-probnp) in diastolic and systolic heart failure (0 replies)
  11. Heart-Failure: The best medicine: exercise training normalizes chemosensitivity and sympathoexcitation in heart failure (0 replies)
  12. Heart-Failure: Exercise training improves peripheral chemoreflex function in heart failure rabbits (0 replies)
  13. Heart-Failure: Defibrillators save lives, don't diminish quality of life, researchers find (0 replies)
  14. Heart-Failure: The under-use of [beta]-blockers for treating chronic heart failure (hf) might be explained by the deteriorations associated with advanced disease. (0 replies)
  15. Heart-Failure: The under-use of [beta]-blockers for treating chronic heart failure (hf) might be explained by the deteriorations associated with advanced disease. (0 replies)
  16. Heart-Failure: Resting hr predictive of heart failure in stable cad. (0 replies)
  17. Heart-Failure: Rosuvastatin doesn't rate in chronic heart failure. (0 replies)
  18. Heart-Failure: Cytokinetics starts third mid-stage test of heart drug (0 replies)
  19. Heart-Failure: Pulmonary hypertension: a review for nurses. (0 replies)
  20. Heart-Failure: Icd do not impact on qol but shocks may signal death risk (0 replies)
  21. Heart-Failure: Cytokinetics, inc.: cytokinetics announces the initiation of third phase iia clinical trial of ck-1827452 (0 replies)
  22. Heart-Failure: Life-saving defibrillators don't diminish quality of life (0 replies)
  23. Heart-Failure: Assessment of a remote monitoring system for implantable cardioverter defibrillators (0 replies)
  24. Heart-Failure: Daily omega-3 reduces chance of fatal cvd event (0 replies)
  25. Heart-Failure: Statin ineffective for heart patients (0 replies)
  26. Heart-Failure: Alcohol consumption may reduce heart failure risk in men with hypertension (0 replies)
  27. Heart-Failure: Defibrillators save lives, don't diminish quality of life (0 replies)
  28. Heart-Failure: New data shows prescription omega-3 acid ethyl esters reduced the incidence of death in heart failure patients (0 replies)
  29. Heart-Failure: New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the euroheart failure survey (0 replies)
  30. Heart-Failure: Optivol may reduce heart failure hospitalisation (0 replies)
  31. Heart-Failure: New data on the benefit of cardiac devices in heart failure patients presented at esc congress 2008 (0 replies)
  32. Heart-Failure: Acute effects of angiotensin ii receptor blocker on ventricular repolarization alternans in chronic heart failure. (0 replies)
  33. Heart-Failure: Cms adds children's health care information to hospital compare web site (0 replies)
  34. Heart-Failure: Cardiac metabolic compensation to hypertension requires lipoprotein lipase (0 replies)
  35. Heart-Failure: Role of p2x purinergic receptors in the rescue of ischemic heart failure (0 replies)
  36. Heart-Failure: Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the nts at1 receptors in heart failure (0 replies)
  37. Heart-Failure: Jolts from heart defibrillators often precede death (0 replies)
  38. Heart-Failure: Defibrillators save lives, don't diminish quality of life (0 replies)
  39. Heart-Failure: Leptin predicts lung function in heart failure patients (0 replies)
  40. Heart-Failure: Icds pay off in longevity without jolt to quality of life (0 replies)
  41. Heart-Failure: Esc: record attendance and clinical pearls are highlights for meeting chair (0 replies)
  42. Heart-Failure: Heart device may not hurt life quality (0 replies)
  43. Heart-Failure: Esc: time-chf raise questions about aggressive treatment in oldest patients (0 replies)
  44. Heart-Failure: Patients with mild to moderate heart failure who receive icd shock therapy are at higher risk of future death from heart failure (0 replies)
  45. Heart-Failure: N-3 pufas reduce mortality and hospital admissions in patients with symptomatic heart failure (0 replies)
  46. Heart-Failure: Original article: quality of life with defibrillator therapy or amiodarone in heart failure (0 replies)
  47. Heart-Failure: Original article: prognostic importance of defibrillator shocks in patients with heart failure (0 replies)
  48. Heart-Failure: Fish oil cut heart failure morbidity and mortality in large study (0 replies)
  49. Heart-Failure: Heart failure implementation (0 replies)
  50. Heart-Failure: Heart failure implementation (0 replies)
  51. Heart-Failure: New european guidelines for the management of acute pulmonary embolism (0 replies)
  52. Heart-Failure: N-3 pufas reduce mortality and hospital admissions in patients with symptomatic heart failure (0 replies)
  53. Heart-Failure: Hypertensive us doctors benefit from moderate alcohol consumption (0 replies)
  54. Heart-Failure: Pufa provide modest benefit in hf (0 replies)
  55. Heart-Failure: Cytokinetics, inc.: cytokinetics announces interim clinical trial data relating to ck-1827452 presented at the european society of cardiology congress 2008 (0 replies)
  56. Heart-Failure: European guidelines for acute pulmonary embolism (0 replies)
  57. Heart-Failure: New guidelines on heart failure (0 replies)
  58. Heart-Failure: The most frequently reported postmarketing adverse reactions associated with trastuzumab and rituximab were heart failure and wbc disorders (0 replies)
  59. Heart-Failure: Evidence supports utility of remote patient management and fluid monitoring alerts to potentially reduce heart failure hospitalisations (0 replies)
  60. Heart-Failure: Fish oil supplements help with heart failure (0 replies)
  61. Heart-Failure: Fish oil supplements help with heart failure (0 replies)
  62. Heart-Failure: Fish oil supplements help with heart failure (0 replies)
  63. Heart-Failure: The correlation of left atrial volume index to the level of n-terminal pro-bnp in heart failure with a preserved ejection fraction (0 replies)
  64. Heart-Failure: Daily omega-3 dose lowers cv risk (0 replies)
  65. Heart-Failure: Daily omega-3 dose lowers cv risk (0 replies)
  66. Heart-Failure: The gissi-hf trial: effects of rosuvastatin in 4,574 patients with chronic heart failure (0 replies)
  67. Heart-Failure: Fish oil supplements help with heart failure (0 replies)
  68. Heart-Failure: Time-chf trial: elderly hf patients do not benefit from intensive medical therapy (0 replies)
  69. Heart-Failure: Type d personality predicts health status for chronic heart failure (0 replies)
  70. Heart-Failure: Predictors of in-hospital mortality in patients hospitalized for heart failure (0 replies)
  71. Heart-Failure: Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in heart failure patients with erectile dysfunction (0 replies)
  72. Heart-Failure: Biogen idec to launch broad clinical trial for heart/kidney drug (0 replies)
  73. Heart-Failure: Making the most of routine data in palliative care research - a case study analysis of linked hospital and mortality data on cancer and heart failure patients in scotland and oxford. (0 replies)
  74. Heart-Failure: [original articles] can a change in policy reduce emergency hospital admissions? effect of admission avoidance team, guideline implementation and maximising the observation unit (0 replies)
  75. Heart-Failure: [original articles] efficacy and safety of torasemide in children with heart failure (0 replies)
  76. Heart-Failure: A modeling intervention in heart failure. (0 replies)
  77. Heart-Failure: Pulmonary pressure and cardiac function in chronic mountain sickness patients. (0 replies)
  78. Heart-Failure: Attacking heart failure in the young (0 replies)
  79. Heart-Failure: Secondary prevention of arterial disease in very elderly people: results from a prospective registry (frena) (0 replies)
  80. Heart-Failure: Attacking heart failure in the young (0 replies)
  81. Heart-Failure: Biology of tnfα and il-10, and their imbalance in heart failure (0 replies)
  82. Heart-Failure: 'smoker's paradox' in heart failure not fully explained (0 replies)
  83. Heart-Failure: 'smoker's paradox' in heart failure not fully explained (0 replies)
  84. Heart-Failure: Attacking heart failure in the young (0 replies)
  85. Heart-Failure: Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. (0 replies)
  86. Heart-Failure: Images in cardiovascular medicine. evanescent asymmetrical septal hypertrophy and rapidly progressive heart failure in a 32-year-old man. (0 replies)
  87. Heart-Failure: Optimization of the use of b-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure (0 replies)
  88. Heart-Failure: Pregabalin: decompensation of heart failure: 3 case reports (0 replies)
  89. Heart-Failure: Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. (0 replies)
  90. Heart-Failure: Alternate site pacing in patients at risk for heart failure (0 replies)
  91. Heart-Failure: Fatigue in patients with chronic heart failure - a burden associated with emotional and symptom distress. (0 replies)
  92. Heart-Failure: Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? rationale and design of the diagnostic outcome trial in heart failure (dot-hf). (0 replies)
  93. Heart-Failure: Bacillus cereus endocarditis in a permanent pacemaker: a case report (0 replies)
  94. Heart-Failure: Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy (0 replies)
  95. Heart-Failure: Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system (0 replies)
  96. Heart-Failure: Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure (0 replies)
  97. Heart-Failure: Pregabalin: decompensation of heart failure: 3 case reports. (0 replies)
  98. Heart-Failure: Genotype-phenotype associations between chymase and angiotensin-converting enzyme gene polymorphisms in chronic systolic heart failure patients. (0 replies)
  99. Heart-Failure: Metformin use in decompensated heart failure. (0 replies)
  100. Heart-Failure: Change of p16ink4a and pnca protein expression in myocardium after injection of higf-1 gene modified skeletal myoblasts into post-infarction rats (0 replies)
  101. Heart-Failure: Palatin technologies, inc. reports positive results of phase 2a clinical study with pl-3994 for the treatment of heart failure (0 replies)
  102. Heart-Failure: Sleep apnoea in acute left heart failure before and after cardiac recompensation (0 replies)
  103. Heart-Failure: Utilisation of angiotensin receptor blockers in sweden: combining survey and register data to study adherence to prescribing guidelines (0 replies)
  104. Heart-Failure: Palatin technologies, inc. reports positive results of phase 2a clinical study with pl-3994 for the treatment of heart failure (0 replies)
  105. Heart-Failure: Cardiac resynchromization: race, age, geography matter, study shows (0 replies)
  106. Heart-Failure: Smokers paradox or not in heart failure. just quit (0 replies)
  107. Heart-Failure: The prevalence of erectile dysfunction in heart failure patients by race and ethnicity (0 replies)
  108. Heart-Failure: Angiotensin ii type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. (0 replies)
  109. Heart-Failure: The human g147d-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure (0 replies)
  110. Heart-Failure: Dronedarone: (0 replies)
  111. Heart-Failure: Tnf induction of atrogin-1/mafbx mrna depends on foxo4 expression but not akt-foxo1/3 signaling. (0 replies)
  112. Heart-Failure: Cardiac resynchronization might reduce sleep apnea via less mitral regurgitation (0 replies)
  113. Heart-Failure: Threshold testing at icd implantation 'of little clinical value' (0 replies)
  114. Heart-Failure: Threshold testing at icd implantation 'of little clinical value' (0 replies)
  115. Heart-Failure: Cardiac resynchronization: race, age, geography matter, study shows (0 replies)
  116. Heart-Failure: Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. (0 replies)
  117. Heart-Failure: Reverse remodelling through exercise training is more pronounced in non-ischemic heart failure (0 replies)
  118. Heart-Failure: U.s. hospitals underutilize proven heart failure therapy (0 replies)
  119. Heart-Failure: U.s. hospitals underutilize proven heart failure therapy (0 replies)
  120. Heart-Failure: U.s. hospitals underutilize proven heart failure therapy (0 replies)
  121. Heart-Failure: Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. (0 replies)
  122. Heart-Failure: Inhibition of class i histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. (0 replies)
  123. Heart-Failure: B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure. (0 replies)
  124. Heart-Failure: Stanford, kaiser get $3.89m for heart research center (0 replies)
  125. Heart-Failure: Stanford, kaiser get $3.89m for heart research center (0 replies)
  126. Heart-Failure: U.s. hospitals underutilize proven heart failure therapy (0 replies)
  127. Heart-Failure: Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy (0 replies)
  128. Heart-Failure: Reel syndrome—not a twiddler variant (0 replies)
  129. Heart-Failure: New implant device remotely monitors heart failure patients (0 replies)
  130. Heart-Failure: Early fetal hypoxia leads to growth restriction and myocardial thinning (0 replies)
  131. Heart-Failure: Monthly summaries of nursing research: june 2008 (0 replies)
  132. Heart-Failure: Beta-blocker therapy important in patients hospitalized with heart failure (0 replies)
  133. Heart-Failure: Delays in testing, treatment may impact on adhf outcome (0 replies)
  134. Heart-Failure: Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (results of the spanish atrial fibrillation and resynchronization [spare] study). (0 replies)
  135. Heart-Failure: Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. (0 replies)
  136. Heart-Failure: Prognostic value of n-terminal pro-type-b natriuretic peptide and doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy. (0 replies)
  137. Heart-Failure: Comparison of the prognostic usefulness of n-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. (0 replies)
  138. Heart-Failure: Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failure. (0 replies)
  139. Heart-Failure: Regarding bundle branch block in patients with heart failure. (0 replies)
  140. Heart-Failure: The emerging role of the gut in chronic heart failure. (0 replies)
  141. Heart-Failure: New implant device remotely monitors heart failure patients at northwestern memorial's bluhm cardiovascular institute (0 replies)
  142. Heart-Failure: Choosing quality vs quantity of life in heart failure: decisions often made early (0 replies)
  143. Heart-Failure: Nt-probnp helps identify heart failure in the emergency department (0 replies)
  144. Heart-Failure: Bmi and mortality inversely linked in chf, confirming the obesity paradox (0 replies)
  145. Heart-Failure: Boston scientific announces first uk patients to benefit from next-generation heart devices (0 replies)
  146. Heart-Failure: New implant device remotely monitors heart failure patients at northwestern memorial (0 replies)
  147. Heart-Failure: Molecular identity of the late sodium current in adult dog cardiomyocytes identified by nav1.5 antisense inhibition (0 replies)
  148. Heart-Failure: Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous bmpr2-mutant mice (0 replies)
  149. Heart-Failure: Biventricular pacing in chronic heart failure acutely facilitates the arterial baroreflex (0 replies)
  150. Heart-Failure: Acute heart failure syndromes and coronary perfusion (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.